Maize plants: An ideal production platform for effective and safe molecular pharming

Plant Science

Volumn 174, Issue 4, 2008, Pages 409-419

  Ramessar, Koreen ^a   Sabalza, Maite ^a   Capell, Teresa ^a   Christou, Paul ^a,b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Biosafety; Maize; Plant made pharmaceutical; Regulatory framework; Risk assessment; Transgenic plants

Indexed keywords

ALGAE; ZEA MAYS;

EID: 39749140229     PISSN: 01689452     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plantsci.2008.02.002     Document Type: Review

References (94)

1. Stöger E., Vaquero C., Torres E., Sack M., Nicholson L., Drossard J., Williams S., Keen D., Perrin Y., Christou P., and Fischer R. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol. Biol. 42 (2000) 583-590
2. Stöger E., Sack M., Perrin Y., Vaquero C., Torres E., Twyman R.M., Christou P., and Fischer R. Practical considerations for pharmaceutical antibody production in different crop systems. Mol. Breed. 9 (2002) 149-158
3. Stöger E., Ma J.K.-C., Fischer R., and Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol. 16 (2005) 167-173
4. Ma J.K.-C., Drake P.M.W., and Christou P. The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4 (2005) 794-805
5. Fischer R., Stöger E., Schillberg S., Christou P., and Twyman R.M. Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7 (2004) 152-158
6. Twyman R.M., Stöger E., Schillberg S., Christou P., and Fischer R. Molecular farming in plants: host systems and expression technology. Trends Biotechnol. 21 (2003) 570-578
7. Stöger E., Sack M., Fischer R., and Christou P. Plantibodies: applications, advantages and bottlenecks. Curr. Opin. Biotechnol. 13 (2002) 161-166
8. Commandeur U., Twyman R.M., and Fischer R. The biosafety of molecular farming in plants. AgBiotechNet 5 (2003) ABN 110
9. Goldstein D.A., and Thomas J.A. Biopharmaceuticals derived from genetically modified plants. Q. J. Med. 97 (2004) 705-716
10. US Food and Drug Administration, GRAS (Generally Recognized As Safe) Sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act (1958).
11. Gewin V. Genetically modified corn-environmental benefits and risks. Plos Biol. 1 (2003) 15-19
12. Müntz K. Deposition of storage proteins. Plant Mol. Biol. 38 (1998) 77-99
13. Stoger E., Sack M., Nicholson L., Fischer R., and Christou P. Recent progress in plantibody technology. J. Curr. Pharm. Des. 11 (2005) 2439-2457
14. Abranches R., Marcel S., Arcalis E., Altmann F., Fevereiro P., and Stoger E. Plants as bioreactors: a comparative study suggests that Medicago truncatula is a promising production system. J. Biotechnol. 120 (2005) 121-134
15. Watson S.A. In: Watson S.A., and Ramstad P.T. (Eds). Corn: Chemistry and Technology (1987), Am. Assoc. Cereal Chemists, St. Paul, MN 53-82
16. Giddings G., Allison G., Brooks D., and Carter A. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18 (2000) 1151-1155
17. Ku M.S.B., Agarie S., Nomura M., Fukayama H., Tsuchida H., Ono K., Hirose S., Toki S., Miyao M., and Matsuoka M. High level expression of maize phosphoenolpyruvate carboxylase in transgenic rice plants. Nat. Biotechnol. 17 (2000) 76-80
18. Sparrow P.A.C., Irwin J.A., Dale P.J., Twyman R.M., and Ma J.K.-C. Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res. 16 (2007) 147-161
19. Hood E.E., Witcher D.R., Maddock S., Meyer T., Baszczynski C., Bailey M., Flynn P., Register J., Marshall L., Bond D., Kulisek E., Kusnadi A., Evangelista R., Nikolov Z., Wooge C., Mehigh R.J., Hernan R., Kappel W.K., Ritland D., Li C.P., and Howard J.A. Commercial production of avidin from transgenic maize: characterisation of transformant, production, processing, extraction and purification. Mol. Breed. 3 (1997) 291-306
20. Lamphear B.J., Streatfield S.J., Jilka J.M., Brooks C.A., Barker D.K., Turner D.D., Delaney D.E., Garcia M., Wiggins B., Woodard S.L., Hood E.E., Tizard I.R., Lawhorn B., and Howard J.A. Delivery of subunit vaccines in maize seed. J. Control. Release 85 (2002) 169-180
21. Lamphear B.J., Jilka J.M., Kesl L., Welter M., Howard J.A., and Streatfield S.J. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22 (2004) 2420-2424
22. Streatfield S.J., and Howard J.A. Plant production systems for vaccines. Exp. Rev. Vaccines 2 (2003) 763-775
23. K. Ramessar, T. Rademacher, M. Sack, J. Stadlmann, D. Platis, G. Stiegler, N. Labrou, F. Altmann, J.K.-C. Ma, E. Stöger, T. Capell, P. Christou Cost-effective production of a vaginal protein microbicide to prevent HIV transmission, Proc. Natl. Acad. Sci. U.S.A., in press.
24. Rademacher T., Sack M., Arcalis E., Stadlmann J., Balzer S., Altmann F., Quendler H., Stiegler G., Kunert R., Fischer R., and Stoger E. Recombinant antibody 2G12 expressed in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotech. J. 6 (2008) 189-201
25. Janakiraman V., Steinau M., McCoy S.B., and Trick H.N. Recent advances in wheat transformation. In Vitro Cell Dev. Biol. Plant 38 (2002) 404-414
26. Horvath H., Huang J., Wong O.T., Kohl E., Okita T., Kannangara C.G., and von Wettstein D. The production of recombinant proteins in transgenic barley grains. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1914-1919
27. Hood E.E., Kusnadi A., Nikolov Z., and Howard J. Molecular farming of industrial proteins from transgenic maize. In: Shahidi F., Kolodziejczyk P., Whitaker J.R., Munguia A.L., and Fuller G. (Eds). Chemicals via Higher Plant Bioengineering (1999), Kluwer/Plenum, New York 127-148
28. Woodard S.L., Mayor J.M., Bailey M.R., Barker D.K., Love R.T., Lane J.R., Delaney D.E., McComas-Wagner J.M., Mallubhotla H.D., Hood E.E., Gangott L.J., Tichy S.E., and Howard J.A. Maize-derived bovine trypsin: characterization of the first large-scale, commercial product from transgenic plants. Biotechnol. Appl. Biochem. 38 (2003) 123-130
29. Law R.D., Russell D.A., Thompson L.C., Schroeder S.C., Middle C.M., Tremaine M.T., Jury T.P., Delannay X., and Slater S.C. Biochemical limitations to high-level expression of humanized monoclonal antibodies in transgenic maize seed endosperm. Biochim. Biophys. Acta 1760 (2006) 1434-1444
30. Twyman R.M., Schillberg S., and Fischer R. Transgenic plants in the biopharmaceutical market. Exp. Opin. Emerg. Drugs 10 (2005) 185-218
31. Streatfield S.J. Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol. J. 5 (2007) 2-15
32. Hood E.E., Bailey M.R., Beifuss K., Magallanes-Lundback M., Horn M.E., Callaway E., Drees C., Delaney D.E., Clough R., and Howard J.A. Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant Biotechnol. J. 1 (2003) 129-140
33. Schillberg S., Emans N., and Fischer R. Antibody molecular farming in plants and plant cells. Phytochem. Rev. 1 (2002) 45-54
34. Chikwamba R.K., Scott M.P., Mejia L.B., Mason H.S., and Wang K. Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc. Natl Acad. Sci. U.S.A. 100 (2003) 11127-11132
35. Hood E.E. Where, oh where has my protein gone?. Trends Biotechnol. 22 (2004) 53-55
36. Drakakaki G., Marcel S., Arcalis E., Altmann F., Gonzalez-Melendi P., Fischer R., Christou P., and Stoger E. The intracellular fate of a recombinant protein is tissue-dependent. Plant Physiol. 141 (2006) 578-586
37. Nicholson L., Gonzalez-Melendi P., van Dolleweerd C., Tuck H., Perrin Y., Ma J.K.-C., Fischer R., Christou P., and Stoger E. A recombinant multimeric immunoglobulin expressed in rice shows assembly dependent subcellular localization in endosperm cells. Plant Biotechnol. J. 3 (2005) 115-127
38. Arcalis E., Marcel S., Altmann F., Drakakaki G., Fischer R., Christou P., and Stoger E. Unexpected deposition patterns of recombinant proteins in post-ER compartments of wheat endosperm. Plant Physiol. 136 (2004) 3457-3466
39. Torres E., Gonzales-Melendi P., Stöger E., Shaw P., Twyman R.M., Nicholson L., Vaquero C., Fischer R., Christou P., and Perrin Y. Native and artificial reticuloplasmins co-accumulate in distinct domains of the endoplasmic reticulum (ER) and in post-ER vesicles. Plant Physiol. 127 (2001) 1212-1223
40. Bhattramakki D., and Kriz A.L. Nucleotide sequence analysis of a novel globulin 1 null allele from the Illinois high protein strain of maize. Plant Mol. Biol. 32 (1996) 1215-1219
41. Ting J.T., Lee K., Ratnayake C., Platt K.A., Balsamo R.A., and Huang A.H. Oleosin genes in maize kernels having diverse oil contents are constitutively expressed independent of oil contents. Size and shape of intracellular oil bodies are determined by the oleosins/oils ratio. Planta 199 (1996) 158-165
42. Nikolov Z.L., and Woodard S.L. Downstream processing of recombinant proteins from transgenic feedstock. Curr. Opin. Biotechnol. 15 (2004) 479-486
43. Menkhaus T.J., Bai Y., Zhang C., Nikolov Z.L., and Glatz C.E. Considerations for the recovery of recombinant proteins from plants. Biotechnol. Prog. 20 (2004) 1001-1014
44. Kamenarova K., Abumhadi N., Gecheff K., and Atanassov A. Molecular farming in plants: an approach of agricultural biotechnology. J. Cell Mol. Biol. 4 (2005) 77-86
45. Baez J., Russell D., and Craig J. Corn seed production of therapeutic proteins moves forward: one company's experience. Biopharm 13 (2000) 50-54
46. Farinas C.S., Leite A., and Miranda E.A. Aqueous extraction of maize endosperm: Insights for recombinant protein hosts based on downstream processing. Process Biochem. 40 (2005) 3327-3336
47. Menkhaus T.J., and Glatz C.E. Antibody capture from corn endosperm extracts by packed bed and expanded bed adsorption. Biotechnol. Prog. 21 (2005) 473-485
48. Azzoni A.R., Takahashi K., Woodard S.L., Miranda E.A., and Nikolov Z.L. Purification of recombinant aprotinin produced in transgenic corn seed: separation from CTI utilizing ion-exchange chromatography. Braz. J. Chem. Eng. 22 (2005) 323-330
49. Snow A. Transgenic crops-why gene flow matters. Nat. Biotechnol. 20 (2002) 542
50. Mikkelsen T.R., Andersen B., and Jorgensen R.B. The risk of crop transgene spread. Nature 380 (1996) 31
51. Snow A., and Morán-Palma P. Commercialization of transgenic plants: potential ecological risks. BioScience 47 (1997) 86-89
52. Ellstrand N.C., Prentice H.C., and Hancock J.F. Gene flow and introgression from domesticated plants into their wild relatives. Annu. Rev. Ecol. Syst. 30 (1999) 539-563
53. Dale P.J., Clarke B., and Fontes E.M.G. Potential for environmental impact of transgenic crops. Nat. Biotechnol. 20 (2002) 574-576
54. Di-Giovanni F., and Kevan P.G. Factors affecting pollen dynamics and its importance to pollen contamination: a review. Can. J. For. Res. 21 (1991) 1155-1170
55. Di-Giovanni F., Kevan P.G., and Nasr M.E. The variability in settling velocities of some pollen and spores. Grana 34 (1995) 39-44
56. M.D. Jones, J.S. Brooks, Effectiveness of distance and border rows in preventing outcrossing in corn, Okla. Agr. Exp. Sta. Techn. Bull. No. T-38, Oklahoma State University, Stillwater, OK, (1950).
57. B. Baltazar, J. Schoper, Maize pollen biology, pollen drift and transgenes, Proceedings of the 56th Corn & Sorghum Seed Research Conference, Chicago, IL, 5-7 December, (2002).
58. B. Baltazar, J. Schoper, Crop to crop gene flow: dispersal of transgenes during field testing and commercialization, Proceeding of the Seventh International Symposium on the Biosafety of Genetically Modified Organisms, Beijing, China. Reviewed in Environ. Biosafety Res. 2 (2003) 43-46.
59. Luna V.S., Figueroa J.M., Baltazar B.M., Gomez R.L., Townsend R., and Schoper J.B. Maize pollen longevity and distance isolation requirements for effective pollen control. Crop Sci. 41 (2001) 1551-1557
60. Blancas L., Arias D.M., and Ellstrand N.C. Patterns of genetic diversity in sympatric and allpatric populations of maize and its wild relative teosinte in Mexico: evidence for hybridization. Scientific Methods Workshop: Ecological and Agronomic Consequences of Gene Flow from Transgenic Crops to Wild Relatives (2002), Ohio State University, Columbus 31-38
61. Baltazar B.M., Sanchez-Gonzalez J.J., De la Cruz-Larios L., and Schoper B.J. Gene Flow in Maize (Zea mays L.), Proceedings of the III Congresso Brasileiro de Biosseguranca. III Symposio Latino Americano de Productos Transgenicos. 24-27 September (2003) 165-170
62. Wilkes H.G. Maize and its wild relatives. Science 177 (1972) 1071-1077
63. J.A. Serratos, M.C. Willcox, F. Castillo-Gonzalez, (Eds.), Gene Flow Among Maize Landraces, Improved Maize Varieties, and Teosinte: Implications for Transgenic Maize, CIMMYT Mexico D.F., Maxico, 1997.
64. Paterniani E., and Stort A.C. Effective maize pollen dispersal in the field. Euphytica 23 (1974) 129-134
65. Emberlin J., Adams-Groom B., and Tidmarsh J.J. The Dispersal of Maize (Zea mays) Pollen (1999), Soil Association: National Pollen Research Unit, University College Worcester, UK
66. Raynor G.S., Eugene C.O., and Janet V.H. Dispersion and deposition of corn pollen from experimental sources. Agron. J. 64 (1972) 420-427
67. Nathan R. Long-distance dispersal of plants. Science 313 (2006) 786-788
68. Brookes G., Barfoot P., Melé E., Messeguer J., Bénétrix F., Bloc D., Foueillassar X., Fabié A., and Poeydomenge C. Genetically modified maize: pollen movement and crop coexistence. Dorchester, UK: PG Economics Ltd. (2004). www.pgeconomics.co.uk
69. A.B. Salamov, About isolation in corn, Sel. I. Sem. 3 (1940) (Russian translation by Michael Afanasiev in 1949).
70. Bateman A.J. Contamination of seed crops II. Wind pollination. Heredity 1 (1947) 235-246
71. Jurgenheimer R.W. Corn: Improvement Seed Production and Uses (1976), Wiley Interscience, New York p. 670
72. A. Messean, Impact du development des plantes transgeniques dans les systemes de culture: rapport final. Dossier No. 96/15- B: Impact des plantes transgeniques (1999).
73. E.C. Simpson, C.E. Norris, J.R. Law, J.E. Thomas, J.B. Sweet, Gene flow in genetically modified herbicide tolerant oilseed rape (Brassica napus) in the UK, Gene Flow and Agriculture: Relevance for Transgenic Crops. P. Lutman, (Ed.) BCPC Symposium Proceedings 72 (1999) 75-81.
74. Burris J.S. Adventitious Pollen Intrusion into Hybrid Maize Seed Production Fields (2003), American Seed Trade Association
75. Baltazar B., and Schoper J. Crop to Crop Gene Flow: Dispersals of Transgenes in Maize: Proceedings of the Seventh Symposium on Biosafety of GMOs (2002)
76. B. Loubet, X. Foueillassar, INRA Thiverval-Grignon Etude mécaniste du transport et du dépôt de pollen de maïs dans un paysage hétérogène. Rapport de fin de projet Convention INSU N° 01 CV 081, 2003.
77. Hoekstra F.A. Water content in relation to stress in pollen. In: Leopold A.C. (Ed). Membranes, Metabolism, and Dry Organisms (1986), Cornell University Press, Ithaca, NY 102-122
78. Buitinik J., Walters-Vertucci C., Hoekstra F.A., and Leprince O. Calorimetric properties of dehydrating pollen; analysis of a desiccation-tolerant and an intolerant species. Plant Physiol. 111 (1996) 235-242
79. Roy S.K., Ragaman S.M.L., and Salahuddin A.B.M. Pollination control in relation to seed yield and effect of temperature on pollen viability of maize (Zea mays L.). Indian J. Agric. Sci. (Cambridge) 65 (1995) 785-788
80. Miller H.I. Will we reap what biopharming sows?. Nat. Biotechnol. 21 (2003) 480-481
81. Al-Ahmad H., Galili S., and Gressel J. Tandem constructs to mitigate transgene persistence: tobacco as a model. Mol. Ecol. 13 (2004) 697-710
82. Murphy D.J. Improving containment strategies in biopharming. Plant Biotech. J. 5 (2007) 555-569
83. http://pewagbiotech.org/resources/issuebriefs/starlink/starlink.pdf
84. Wolt J., Wang K., and Peterson R. Assessing risk of unintended antigen occurrence in food: a case instance for maize-expressed LT-B. Hum. Ecol. Risk Assess. 12 (2006) 856-870
85. H. Bourges, S. Lehrer, Maize and Biodiversity: The Effects of Transgenic Maize in Mexico, Chapter 7 Assessment of Human Health Effects, for the Article 13 Imitative on Maize and Biodiversity, 2003.
86. Hellwig S., Drossard J., Twyman R.M., and Fischer R. Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol. 22 (2004) 1415-1422
87. Boroda E., Jaynes W.F., Zartman R.E., Green C.J., San Francisco M.J., and Zak J.C. Enzyme-Linked ImmunoSorbent Assay measurement of castor toxin in soils. Commun. Soil Sci. Plant Anal. 35 (2004) 1185-1195
88. Guidance for Industry. Drugs, Biologics and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals (2002), Food and Drug Administration. www.fda.gov/cber/gdlns/bioplant.pdf
89. EMEA, Guideline on the Quality of Biological Active Substances produced by Stable Transgene Expression in Higher Plants. (EMEA/CHMP/BWP/48316/2006) [Draft], European Agency for the Evaluation of Medicinal Products, London, UK, 2006.
90. Ma J.K.-C., Barros E., Bock R., Christou P., Dale J., Dix P.J., Fischer R., Irwin J., Mahoney R., Pezzotti M., Schillberg S., Sparrow P., Stoger E., and Twyman R.M. European Union Framework 6 Pharma-Planta Consortium Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep. 6 (2005) 593-599
91. Ma J.K.-C., Chikwamba R., Sparrow P., Fischer R., Mahoney R., and Twyman R.M. Plant-derived pharmaceuticals-the road forward. Trends Plant Sci. 10 (2005) 558-580
92. Raybould A. A comparison of ecological and ecotoxicological methods of research into the environmental risks of transgenic crops. Plant Sci. 173 (2007) 589-602
93. K. Ramessar, T. Capell, P. Christou, Molecular pharming in cereal crops, Phytochem. Rev., in press, doi:10.1007/511101-008-9087-3.
94. Guerrero-Andrade O., Loza-Rubio E., Olivera-Flores T., Fehérvári-Bone T., and Gómez-Lim M.A. Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res. 15 (2006) 455-463